On Friday, the FDA approved Neffy, the first nasal spray to be used as an emergency treatment for the tens of millions of Americans at risk of potentially life-threatening allergic reactions. CBS News medical contributor Dr. Celine Gounder explains what to know about the new needle-free alternative to the EpiPen. Air Date: Aug 12, 2024